Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 214.00
Bid: 213.50
Ask: 214.50
Change: 3.00 (1.42%)
Spread: 1.00 (0.468%)
Open: 218.00
High: 218.00
Low: 211.00
Prev. Close: 211.00
AMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- Advanced Medical Solutions Group Plc

17 Mar 2010 09:36

RNS Number : 7159I
Artemis Investment Management
17 March 2010
 

FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the Takeover Code)

 

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

Artemis Investment Management Ltd

Company dealt in

Advanced Medical Solutions Group Plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

5p ordinary

Date of dealing

16 March 2010

 

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

 

Long

Short

 

 

Number (%)

Number (%)

(1) Relevant securities

 

5,757,352 (3.97%)

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell

 

Total

 

5,757,352 (3.97%)

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

Class of relevant security:

 

Long

Short

 

 

Number (%)

Number (%)

(1) Relevant securities

 

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell

 

Total

 

 

(c) Rights to subscribe (Note 3)

 

Class of relevant security:

 

Details

 

 

 

 

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale

 

Number of securities

Price per unit (Note 5)

Sale

75,000

0.425333

GBP

 

 

(b) Derivatives transactions (other than options)

 

Product name,

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

 

 

 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price

Type, e.g. American, European etc.

Expiry

date

Option money

paid/received per unit (Note 5)

 

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8)

 

Details

Price per unit (if applicable) (Note 5)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

NONE

 

 

 

Is a Supplemental Form 8 attached? (Note 9) NO

 

 

Date of disclosure

17 March 2010

Contact name

Nicola Collins

Telephone number

0131 718 0429

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

 

 

Notes

 

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETGCGDXXXBBGGR
Date   Source Headline
5th Sep 20067:01 amRNSInterim Results
29th Aug 20067:02 amRNSPositive reclassification
23rd Aug 20067:01 amRNSNorthern Ireland NHS Contract
9th Aug 20069:03 amRNSNotice of Results
12th Jul 20063:36 pmRNSHolding(s) in Company
20th Jun 20067:00 amRNSEuropean Product Approval
13th Jun 20067:02 amRNSGrowth Company Investor Show
12th Jun 20062:45 pmRNSHolding(s) in Company
8th Jun 20067:03 amRNSStrengthened IP Portfolio
31st May 20063:42 pmRNSAGM Statement
11th Apr 20067:00 amRNSBoard Appointment
7th Apr 20064:24 pmRNSHolding(s) in Company
29th Mar 20067:01 amRNSNHS Trust Adopts Products
21st Mar 20067:04 amRNSISO Approvals
20th Mar 20064:10 pmRNSHolding(s) in Company
14th Mar 20067:03 amRNSPreliminary Results
9th Mar 20067:01 amRNSStrategic Partnership
7th Mar 200611:18 amRNSNotice of Results
28th Feb 20067:05 amRNSApproval in China
13th Feb 20067:01 amRNSInnovation in Action
2nd Feb 20067:01 amRNSStengthened Commerical Group
22nd Dec 20054:00 pmRNSDirector Shareholding
15th Dec 20059:47 amRNSHolding(s) in Company
15th Dec 20057:00 amRNSDirector Shareholding
14th Dec 20057:00 amRNSTrading Update
28th Nov 20052:31 pmRNSMP opens new line
24th Nov 20052:00 pmRNSActivHeal* cuts NHS spend
14th Nov 20057:01 amRNSChange of Adviser
21st Oct 200512:33 pmRNSHolding(s) in Company
14th Oct 20054:27 pmRNSHolding(s) in Company
13th Oct 20057:00 amRNSStatement re Director Options
12th Oct 20057:01 amRNSProgress in Japanese Market
7th Oct 20059:52 amRNSHolding(s) in Company
15th Sep 20051:31 pmRNSHolding(s) in Company
6th Sep 20057:01 amRNSInterim Results
6th Jul 20057:00 amRNSEuropean Launch
24th Jun 20053:06 pmRNSHolding(s) in Company
3rd Jun 200510:21 amRNSHolding(s) in Company
24th May 200512:29 pmRNSAGM Statement
10th May 200512:35 pmRNSHolding(s) in Company
9th May 20054:18 pmRNSHolding(s) in Company
5th May 20059:29 amRNSDirector Shareholding
4th May 20059:02 amRNSDirector Shareholding
3rd May 20057:00 amRNSAgreement with Baxter
5th Apr 20057:01 amRNSUS LiquiBand Collaboration
16th Mar 20057:00 amRNSPreliminary Results
15th Mar 20054:36 pmRNSHolding(s) in Company
24th Feb 20054:03 pmRNSNotice of Results
8th Feb 20057:00 amRNSCE Mark European Approval
31st Jan 20055:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.